Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iodopovidone vs Talc for Malignant Pleural Effusion
NCT02674243Phase 3Completed
- Sponsor
- Chiang Mai University
- Start
- Nov 2015
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of povidone-iodine in malignant pleural effusion (MPE) (2 arms), sponsored by Chiang Mai University. Primary endpoint: Success of treatment at 7 days. Started Nov 2015; status: completed.
02
Drugs
povidone-iodine
03
Conditions
malignant pleural effusion (MPE)
Beyond the preview
Go deeper on NCT02674243.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02674243.